Targeting liposomes toward novel pediatric anticancer therapeutics. - Wikidata - awgldk - TriplyDB

Targeting liposomes toward novel pediatric anticancer therapeutics.

Targeting liposomes toward novel pediatric anticancer therapeutics.

http://www.wikidata.org/entity/Q37684734

about

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906).Nanopediatrics: enabling personalized medicine for children.Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.

P2860

Q36957962-266540C0-3EE8-4ED5-8120-A735200AA631 Q37684727-3162D82D-0DA0-40D7-BC37-DF5ABDBE225B Q37983912-5844D6E7-DD8D-453F-AF93-2086FAA6855E Q38825691-0AD7EEA0-759E-4F7A-B48C-AA3747618ED2 Q38909208-ABA578CD-F7C1-42C0-945B-A126D504CA99 Q39527980-C76197AD-DFAF-498C-AC4E-85845C17174A Q54326868-EC9343C7-1261-49CE-AF6F-B7F118285AD5

P2860

Targeting liposomes toward novel pediatric anticancer therapeutics.

http://www.wikidata.org/entity/Q37684734

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting liposomes toward novel pediatric anticancer therapeutics.

@en

Targeting liposomes toward novel pediatric anticancer therapeutics.

@nl

type

label

Targeting liposomes toward novel pediatric anticancer therapeutics.

@en

Targeting liposomes toward novel pediatric anticancer therapeutics.

@nl

prefLabel

Targeting liposomes toward novel pediatric anticancer therapeutics.

@en

Targeting liposomes toward novel pediatric anticancer therapeutics.

@nl

P1433

Q37684734-D9442CD2-C734-4F91-BDD1-0885F6B68897

P1476

Q37684734-D17278AA-3808-451F-86A0-AB4E61597F50

P2093

Q37684734-40284A03-77C2-467A-9BED-B5AF9586838B

Q37684734-D061B95F-64AF-4EDF-9B96-1F0C708EBC93

P2860

Q37684734-0218CE7C-CC37-4B04-A640-08A4725A8933

Q37684734-169B6A1D-D427-40BA-B2FC-6FBB88339DBA

Q37684734-18F95ACB-3080-4D57-9D67-9A0237CBBB2F

Q37684734-1D98B84F-1535-4590-8B89-ED8C38C99D8E

Q37684734-25FFF329-24B9-4B59-B146-B33A2B795822

Q37684734-286E8142-D9E5-48EF-93AC-23061D5CF141

Q37684734-2F164AC4-30E3-4EE2-884E-FF881EADE16A

Q37684734-323A0ADC-BD79-4EBB-B646-55638AFAF8E4

Q37684734-3BD6EDA7-A3FE-4CBB-88CC-CD94FC04D8C3

Q37684734-3E57404F-FF6A-4C34-A77E-8798E47FFE74

P2888

Q37684734-C530383F-DC3D-4338-AFB0-05E4100A8C05

P304

Q37684734-94A2C098-AA86-4656-BDC7-67D3EA52E03F

P31

Q37684734-2A04DCFB-B4A7-46B0-8CFA-C3007BC51C07

P356

Q37684734-6F0E8428-A56D-4D44-BEF2-461BDE5CD900

P407

Q37684734-C6184241-F5B6-4963-B069-E2DE77C970CA

P433

Q37684734-273D6A64-E249-4ADC-9372-9BF79D0EB95A

P478

Q37684734-AF1F60E2-BBC0-4C10-A300-0AE6F2E6A509

P577

Q37684734-339265F6-6B83-498D-B88F-05081981520D

P5875

Q37684734-642D7EC9-C7FB-443F-9EB6-A4B72EF3BCB7

P6179

Q37684734-52BE61FC-82FD-4DCF-B92D-7B098978982E

P698

Q37684734-96FD2B22-58E4-48D4-B6E2-F274BAA0EDB0

P356

PDR.0B013E3181D601C5

P1433

Pediatric Research

P1476

Targeting liposomes toward novel pediatric anticancer therapeutics.

@en

P2093

Christopher T Denny

http://www.w3.org/2001/XMLSchema#string

Noah Federman

http://www.w3.org/2001/XMLSchema#string

P2860

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer

Nanocarriers as an emerging platform for cancer therapy

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Drug transport to brain with targeted liposomes

Blood-brain barrier drug targeting: the future of brain drug development.

Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide

Liposomal anthracyclines in metastatic breast cancer: clinical update.

The 'right' size in nanobiotechnology.

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.

P2888

pdr.0b013e3181d601c5

P304

514-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1203/PDR.0B013E3181D601C5

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41191884

http://www.w3.org/2001/XMLSchema#string

P6179

1020302996

http://www.w3.org/2001/XMLSchema#string

P698

20118828

http://www.w3.org/2001/XMLSchema#string